top of page

CorNeat Vision Completes Pre-clinical Phase For Synthetic Cornea and Scleral Patch

September 2019

Innovative synthetic biology implants to be showcased at the 37th Congress of the ESCRS 2019 Paris

TEL AVIV, Israel, Sept. 9, 2019 /PRNewswire/ -- CorNeat Vision, an Israeli ophthalmic medical solution company, announced today it has completed the pre-clinical stage of its revolutionary cornea implant (CorNeat KPro / Keratoprosthesis) and the first synthetic, non-degradable scleral patch (CorNeat EverPatch). The company's solutions, which also include a revolutionary glaucoma drainage device, the CorNeat eShunt, will be showcased for the first time at the 37th Congress of the ESCRS (European Society of Cataract and Refractive Surgeons) in Paris, France on September 14th-18th, 2019.

Read more of this press release at:

bottom of page